Will we soon use a CBD-based drug to help people quit smoking? And what's CBN and how can it help us sleep?
On episode 21 of the Ministry of Hemp Podcast, Matt talks about a new pharmaceutical drug that uses synthetic CBD and nicotine to help people quit smoking. After that Matt has a conversation with Pure American Hemp Oil Co-Founder Spencer Schelp about their new CBN tincture for sleep, and why some consumers want to include the cannabinoid CBN in their healthcare routine.
Here's some links from Leafly on CBN's sedating effects and some more information from High Times and PopSugar.
Can natural compounds found in hemp, like the cannabinoid CBD, contribute to quitting smoking and help end other addictions?
Here's some more links explaining how some people have used CBD to quit smoking or ease the effects of other addictions:
We want to hear from you too. Send us your questions and you might hear them answered on future shows like this one! Send us your written questions to us on Twitter, Facebook, email [email protected], or call us and leave a message at 402-819-6417. Keep in mind, this phone number is for hemp questions only and any other inquiries for the Ministry of Hemp should be sent to [email protected].
Thanks again for listening! Contact [email protected] if you’re interested in sponsoring our podcast or other content on our website.
Below you'll find the complete written transcript for this episode:
Matt Baum: 00:02 Welcome to another episode of the Ministry of Hemp Podcast. I'm your host, Matt, and this show is of course brought to you by ministryofhemp.com, America's leading advocate for hemp education where you can find information about all things hemp all the time.
Matt Baum: 00:18 Today on the show we are going to talk about a specific cannabinoid called CBN. We're going to talk about how it's different than CBD, what it does, and why people want to incorporate CBN into their health regimen. So today on the show I'm going to sit down for a conversation with Spencer Schelp. He is one of the owners and cofounders of Pure American Hemp Oil. You might remember just a few episodes ago when Ian Erickson, the other founder from Pure American Hemp Oil, came on and talked about their mission. Well, today he's going to talk about their new CBN tincture and why you might be interested in CBN. But before we get into that, let's talk a little bit about hemp in the news.
Matt Baum: 01:10 If you've been listening to the show, you've probably heard me mention the drug Epidiolex, which is the first FDA-approved drug using CBD as an ingredient to treat seizures in children. Now, Epidiolex was a huge story but it is not the only drug that is now seeking FDA approval using CBD as its main ingredient. CV Sciences out of San Diego is probably best known for their PlusCBD Oil. If you've spent some time over at ministryofhemp.com, you may have seen their name.
Matt Baum: 01:44 CV Sciences also has a pharmaceutical division and currently they're working on a medication known for now as CVSI-007 to treat nicotine addiction and help people stop using smokeless tobacco products. Now, a lot of nicotine addiction is treated by supplementing a different type of nicotine for the nicotine that was in cigarettes. Think vaping, think Nicorette Gum or NicoDerm patches. All of which give the body the nicotine that you are craving without a cigarette.
Matt Baum: 02:18 The theory here is if you're trying to kick nicotine, let's kick nicotine. So they've developed a drug that is still pending FDA approval, but the idea is to make CBD with nicotine because according to Joseph Dowling, CEO of CV Sciences, the two compounds can have similar effects on the body, not necessarily the addictive effects, but physiological effects. The CBD that they're using for this drug is completely synthetic, so it's not coming from a hemp plant, which the FDA probably likes, and will probably help them get approved faster.
Matt Baum: 02:55 I've been very plain about my feelings about synthetic hemp on this show, and I'm not going to go into the argument here. According to Dowling though, there are mechanisms of action of CBD that mimic what nicotine does in the body, except CBD is potentially stronger with a much greater half-life. Half-life meaning it stays in the body longer. So they believe that the therapeutic range of a combination drug could be very effective for the treatment of nicotine addiction.
Matt Baum: 03:22 Currently, CVSI-007 is in preclinical development, which means it's undergoing extensive safety toxicological analysis, which basically means they need to make sure it's safe and it doesn't poison anybody first. If the clinical results are successful and they do get FDA approval, that could mean that CBD could be used in the future to treat all manner of addiction. One thing that is for certain, swapping nicotine for a different kind of nicotine is not an effective way to kick a nicotine habit, and that is essentially what smoking is, a nicotine habit. While it hasn't been approved yet and there is no real timeline, this stuff can take quite a while, CV Sciences was hoping to have FDA approval by the end of the year, so watch the news. Perhaps early next year, there'll be a whole new way for you to quit smoking.
Matt Baum: 04:24 We talk about CBD a lot on this show and it is just one of several cannabinoids that scientific tests are showing have real benefits to the human body. One of the newest, most exciting cannabinoids out there is CBN. My next guest on the show is not a chemist, and he'll remind you of that later on, but he's a pretty smart guy and he's got a very cool company that's putting out a new CBN tincture. This is my conversation with Spencer Schelp from Pure American Hemp Oil about CBN, what it does and why you might want to include it in your regimen if you're having trouble sleeping.
Matt Baum: 05:07 Now, Spencer, we recently talked to Ian not too long ago about Pure American Hemp Oil's mission and how that the company came about. Today however, Ian has volunteered you to talk about CBN. Do you feel qualified for this?
Spencer Schelp: 05:23 Oh, as qualified as I'll be at this point. Yeah.
Matt Baum: 05:25 Fair enough. Now I know there's different isolates that we look for in products, but can you tell me why do I want to look for CBN? What is it and what does it do?
Spencer Schelp: 05:36 Well, CBN is, it's one of a hundred or so cannabinoids from the hemp plant, from the cannabis plant. It's recently, I'd say recently, but yeah, it's fairly recently been identified and isolated I guess to a commercial level to where we can get it out and use it as an isolate, as an extract, as a distillate and start formulating product with it. It's got numerous properties, benefits if you will, but obviously I can't make any claims, but as a sedative, right? You know, it's been lauded as a sedative. I think it's the Smithfield Laboratory says-
Matt Baum: 06:15 Spencer says Smithfield Lab. It's actually Steep Hill Labs and I'll have a link to that study in the show notes.
Spencer Schelp: 06:21 They've got a study out there that says that about two and a half milligrams of CBN is the equivalent of a five milligram diazepam.
Matt Baum: 06:28 Really?
Spencer Schelp: 06:29 So that for our target audience, that was something we took note of.
Matt Baum: 06:34 That's kind of amazing. I had not heard that.
Spencer Schelp: 06:37 Yeah, yeah.
Matt Baum: 06:38 Wow.
Spencer Schelp: 06:38 That's what perked our ears up because again, we're a… You know, Ian's a veteran. We're a veteran owned company, made in the US and everything, and we give veterans, first responders, educators, they get 25% off and free shipping all the time, all day, every day. So we always look at that niche.
Matt Baum: 06:53 Yeah. We have actually links to you guys on ministryofhemp.com as one of the companies that works with people that need financial aid. That is awesome. Thank you guys for doing that.
Spencer Schelp: 07:04 Well, we appreciate you guys. We've been having a pretty longstanding relationship at this point. I think we won the best gummy back probably three years ago with you guys. That was cool. You know what I mean? We're proud to still be in business and proud to see how you guys have grown and been keeping everybody honest in the industry. So…
Matt Baum: 07:22 Right on.
Spencer Schelp: 07:22 Outside of that, yeah, it's good stuff. We're always looking for our core market, right? You know, when we first started this thing back three, four years ago and kind of was like, "Well we got to get CBD brand," boom, you know, "pay me." And that's not really how it shook out, right?
Matt Baum: 07:41 Right.
Spencer Schelp: 07:41 You got to have a market, you got to have a value prop, and you've got to have buyers. We really found our niche with that veteran community and with that being zero THC in the beginning is quite an expensive thing because we had to find oils and distillates and everything that were zero THC and that was hard to do earlier on. It was more expensive. But at the same time, with our core audience, they can't piss dirty. I mean, there's zero tolerance to that.
Matt Baum: 08:08 Exactly.
Spencer Schelp: 08:10 So we spend a lot of money keeping consistent product and testing, right? We got to make sure that our tests are right. We just picked up another sponsored athlete, Pat Downey. He's one of the best grapplers in the world and with any luck he's going to represent us. He'll be on the Olympic team with any luck coming up here in 2020.
Matt Baum: 08:27 That's very cool.
Spencer Schelp: 08:29 Yeah. It's cool. I mean, we're we're pleased. That's another great niche for us. Grappling, sports, martial arts, jujitsu, things like that. Those are people that have pain, that have symptoms and that need a daily use product. Right? With that, we're not trying to-
Matt Baum: 08:46 Yeah. Same pain, different injuries. That's all it is. Right?
Spencer Schelp: 08:49 Yeah. We've found through testimonials and just talking through ourselves as well and talking with our client base that we're not trying to stack another thing, another cost onto you every month. Right?
Matt Baum: 09:02 Right.
Spencer Schelp: 09:02 I mean, if we found that if you can take our product and it's going to eliminate maybe a pharmaceutical or maybe a couple of things that you're already taking and it does a better job and it's less expensive, that's a huge win for us, right?
Matt Baum: 09:14 Of course.
Spencer Schelp: 09:14 And people they're just fine that amount of money to go around. So we're very sensitive to that and our price points have tried to reflect that. Right? We didn't get out there in the beginning and jack stuff up and then bring it down, and we're really trying to do the same thing with the CBN. Right? I mean it might be the hot thing right now, and in a year from now, it's not going to be so hot. I mean, it's going to be a little more mainstream I'd imagine, but we don't want to be spiking the price and bringing it back down.
Spencer Schelp: 09:40 When we launched it, we launched it at a modest level at a 150 milligrams of CBN. Now there's still CBD in there and we also put melatonin in there because sleep was the other component. It's researched and there aren't a lot of claims about that but it does work well for sleep at least for me. Those are the big ones. A pain reliever, as an antibiotic and anti-inflammatory. We're also seeing as far as glaucoma, relieves the pressure on your eyes, essentially it lowers that and winds your-
Matt Baum: 10:12 Inflammation, right? You treat inflammation with this stuff and it helps.
Spencer Schelp: 10:12 Yeah, inflammation. Those have been the big ones. Then I think we'll see a little bit further down the road for bone healing. STEM cells, right? So those do a variety of things as your body needs them. Kind of like cannabinoids, right? I mean wherever your body is going to take those and make the best use of those as your body chemistry dictates. So those are all things that we're pretty excited about.
Spencer Schelp: 10:36 And then one thing we found as well, actually Ian reported it to me. We've trade notes on this stuff as we're testing this stuff, and he's like, "You know, I don't know what it does for my sleep, but it sure makes me hungry. And then I eat and then I don't sleep."
Matt Baum: 10:53 It could be different for different people basically. I mean just like anything else, right?
Spencer Schelp: 10:57 Yeah, exactly. Everybody's got different body chemistry, right? So you're going to take that and use that. Your body is going to use that as needed. So if you look at the cross section of all that for sleep, for bone growth, glaucoma, pain relief, inflammation, all those things, I mean not entirely different than CBD but it all works together with your body-
Matt Baum: 11:17 So there's more of a sedative property to CBN than there is to CBD.
Spencer Schelp: 11:20 Correct.
Matt Baum: 11:21 Okay.
Spencer Schelp: 11:25 It's THC that's been oxidized. It's not psychoactive, but that's the nuts and bolts of it. It's like THC that's been oxidized and it's just a little more mature if you will. So for appetite, bone growth, things like that, and then you stack the sedative and then some sleep properties, it's a pretty exciting piece for us. We've had really good feedback and we're pretty pleased with it. It's difficult to source it. And that's what took us a while because it's essentially derived from CBG through chromatography.
Matt Baum: 11:56 Okay. Let's talk about that for a second. I'm curious. You were saying like sourcing CBN. Is that a whole different plant? I mean, when I say plant, like a different version of hemp that you would get CBD from?
Spencer Schelp: 12:11 No, it's not. It's just going to be a different strain essentially. You want a high CBG strain with good CBG properties because you're going to convert that CBG over to CBN, and we found that the people were using… do that through chromatography. A lot of times that would be… Well, you could do that by stripping a high THC out as well. But then again, you're going to have to go to a state or a lab that works with cannabis, with marijuana and stuff, so it was a little-
Matt Baum: 12:40 Which can be really difficult.
Spencer Schelp: 12:42 Yeah, exactly. So you narrow your options there and then you got to make sure that it's going to be consistent and those strains are going to be consistent. You're not going to be putting the same thing in the bottle today that I am next month and next year. So that's a big thing is making sure that the legs are going to be there for it.
Matt Baum: 12:58 Let me ask you about your guys' process and you don't have to reveal any secrets or anything, but is the process to extract CBN, is it any different than CBD?
Spencer Schelp: 13:11 No. No, it's not. Not really. It's just you're going to go about it through different cannabinoids. So again, CBG is like the mother cannabinoid and you can convert that over to CBN, right? So instead of just going in there and finding like, okay, this cherry wine has got 16% CBD, okay, boom, let's extract that out which are crude and then break that down to a distillate or whatever. You know, you're just looking for different strains. Right?
Spencer Schelp: 13:39 CBG, fortunately has come on the last year or two. So we've got some more of that on the market. There's more options there. So you're going from CBD, which there's not a lot of. I guess I know who you talk to. Then you're going to CBG and then you're taking that [inaudible 00:13:55] into CBN. So you're really going through a couple of filters there to end up with your end product.
Matt Baum: 13:59 Okay.
Spencer Schelp: 13:59 So again, like consistency and you're seeing anywhere from 45 to $65,000 a kilo, a gross kilo.
Matt Baum: 14:06 Wow.
Spencer Schelp: 14:06 So yeah, it's dear, but at the same time it's going to follow the same trend I think that CBD did two, three years ago. You know what I mean? It's going to-
Matt Baum: 14:14 Sure. I mean as it begins more popular, there'll be more of it, more processors, and the price comes down.
Spencer Schelp: 14:19 Exactly.
Matt Baum: 14:19 Right.
Spencer Schelp: 14:20 We're seeing a lot more in the market. Even in the last month or two, we've seen a lot more out there. You know, I saw one yesterday and maybe this is a marketing piece we could have taken a trick from, but it was a thousand milligrams but it sells like 60 milligrams of CBN and the rest of it was CBG or CBD. Right? So we just went straight 150 because that's what the active is on the CBN. But then we spiked it with a little melatonin for the sleep property.
Matt Baum: 14:49 That's important though. You guys are telling the truth. This other company is like yeah, they're representing some of what's in there, but you got to read the fine print brother, you know? I mean come on.
Spencer Schelp: 14:56 Well, yeah. Yeah, yeah, yeah.
Matt Baum: 14:59 That's not so great.
Spencer Schelp: 15:00 It's not like going to Amazon but at the same time… No, it was great brand, beautiful brand, beautiful bottle, and everything. But I was like, "Man, we just missed the boat here." And I was like, "Ah, there we go. That's what it is."
Matt Baum: 15:10 I don't know.
Spencer Schelp: 15:10 So yeah, you got to flip that over and-
Matt Baum: 15:12 Yeah. I think in my opinion, you guys are doing it a little more straightforward and I appreciate that. I think that's better for everybody.
Spencer Schelp: 15:18 Yeah, no, thank you. I mean, we've been spending a lot of time on boxes and labels and labs lately and kind of just getting up to the point where we feel like we're a step or two ahead of where things will be in a year or so so we can focus on product as opposed to just getting product out there. We can kind of innovate a little bit more. But yeah, it's been a good run so far. I've been staying busy, that's for sure.
Matt Baum: 15:43 So where are you guys sourcing the hemp that you're getting CBN from? Is it from a completely different farm than the CBG hemp? Pardon me. I mean than the CBD hemp. Sorry.
Spencer Schelp: 15:51 You know what that is? Yeah, it is. Actually, most everything where we get is… All of our other products come out of Tennessee out of our farm partner over there. It's Wilson's farm. And then that's extracted out into the just splitting the crude and then formulate that out as needed. Then the labs and the manufacturing out there also had some of the isolate on a contract. Right? So consistency is huge. Having those same strains, having the same stuff in the bottle right not just who's got what for the least amount of dollars out there.
Matt Baum: 16:27 Like you said, maintaining zero THC so that people like veterans and people that are police officers that are tested aren't failing tests basically.
Spencer Schelp: 16:38 Exactly. The consistency is huge. That's the big thing. That's the big thing and that's what we… We really had to lay that baseline down. Early on, you know that you've got our feet knocked out from us a couple of times just with different groups raising prices, holding product back, this, that, and the other, but that it's kind of back in there. Everybody's got their stories.
Spencer Schelp: 16:58 Anyway, yeah, we're very pleased to have consistent farm partners and people that are really up on the bottling, the formulation, everything that we work with, and take it just as seriously as we do. But yeah, so we've been sourcing the CBN from a different group and that's been pretty strong with the CBG and then they got into the CBN and stuff. That's what took us to kind of get up to speed on and make sure that we're on the same page quality wise and consistency and everything. That was also our step to… Go ahead.
Matt Baum: 17:33 Just for my sake and for our listeners' sake, we're throwing out a lot of letters here. Correct me if I'm wrong. CBG becomes CBN, correct?
Spencer Schelp: 17:43 It can, yeah. In this case, it does, yeah, through the essentially another extraction process. Yes.
Matt Baum: 17:49 Gotcha. Is it more work than just making… I mean, obviously you're taking two products and putting them into one bottle, but is it more work to distill the CBN than it is the CBD or is it just same plant, same process, different final result?
Spencer Schelp: 18:07 Kind of both, right? You're going to have a different strain, a different raw materials going in. Right? So it's going to be a CBD and a CBG rich strain and then you're going to extract out and you're going to convert that CBG into CBN.
Matt Baum: 18:21 Okay. That's done with what you called chromatography. Is that right?
Spencer Schelp: 18:25 Correct.
Matt Baum: 18:26 Tell me a little bit about that. I don't know what that is.
Spencer Schelp: 18:29 Well, it's similar process to ripping out the THC from a CBD distillate for us to sell.
Matt Baum: 18:38 Okay.
Spencer Schelp: 18:39 So there is more that goes into it. There's just more time.
Matt Baum: 18:43 Earlier in the interview, Spencer had mentioned that he's not a chemist, so it wasn't really fair for me to ask him to define chromatography, but huge thanks to Wikipedia who I just donated to and you should too because they're doing a good thing.
Matt Baum: 18:56 Wikipedia defines chromatography as a laboratory technique for the separation of a mixture. Picture your favorite sci-fi movie where you see the scientist pouring a liquid into a flask and placing it into a machine that spins it around really fast. In this case, they would be separating CBN from the rest of the cannabinoids.
Matt Baum: 19:16 Now, I'm sure that explanation is impossibly oversimplified, but in a nutshell, that is chromatography.
Spencer Schelp: 19:22 That's why it's a little more expensive and not as prevalent because most everybody is turning stuff into CBD in some shape or fashion.
Matt Baum: 19:28 Right. But the basic idea is you're putting it through a similar process where you are isolating that thing that you want, taking that thing out, and then putting it back into a bottle with the other thing that you want more or less.
Spencer Schelp: 19:43 Essentially, yeah. You can think of CBG as the mother cannabinoid. I'm not a chemist, so I don't really have any secrets to share, but going through and talking with the people that we've interviewed and everything on this, you're taking that CBG rich strain and then you're converting that out and you're getting your CBN out of that.
Matt Baum: 20:07 Okay.
Spencer Schelp: 20:07 So it's like if you look at a full panel lab, right, of a distillate, you'll see the minor cannabinoids are going to be those CBGs, the CBNs, CBCs. You know, they're prevalent in almost every strain except for you want to find a strain that's going to be more rich in like a CBG. So you'll have more yield from that. Right?
Matt Baum: 20:28 Okay. So CBD and CBG are separate things, correct.
Spencer Schelp: 20:32 Yeah. It's just another cannabinoid.
Matt Baum: 20:34 Gotcha. And CBD is technically the… Well, I guess THC is probably the most prevalent, but CBD, we have grown plants that make that the most prevalent. So you are looking beyond that to one that also has a very high level of CBG, and that is what turns into CBN.
Spencer Schelp: 20:52 Yeah, in this case. So you've got cannabis, right? Then you've got the-
Matt Baum: 20:54 Okay. I feel like I'm finally wrapping my head around this. Sorry.
Spencer Schelp: 20:57 Yeah. Right? It's almost like a back in the day, everybody wanted super high THC, so you've got cannabis and you've got marijuana, which they're breeding up for super high THC. And then a few years back, you found that CBD had its own benefits. So we started breeding cannabis and industrial hemp now into high CBD strains.
Spencer Schelp: 21:22 So guys are out there, breeders and crossbreeding stuff and everything and identifying and isolating these other minor cannabinoids. That's where all this is going. I mean this opened up obviously with the farm bill and everything, but now that CBD again is just one cannabinoid of up hundreds. So as these are all identified and then God forbid we get some clinical trials down or something that we can really stand behind this stuff and point to it.
Matt Baum: 21:47 Who knows? You've really your fingers, you know?
Spencer Schelp: 21:49 Yeah, right. Yeah. But the more those were identified, the more incentive, the market is going to move that. The market is going to say this is something that we demand and this is something that we're going to pay for, and then people move in that direction just like CBD. So we kind of set out the CBG for no other reason. Not mad at it, just kind of cleaning house and getting our brand up to a level essentially. And then the timing was right to kind of jump on this and especially, like I say, for the properties that our users are really… That they value. I mean this makes a lot of sense for us.
Matt Baum: 22:26 Of course.
Spencer Schelp: 22:26 It's not an end all cure all or anything obviously, but it's a new product that we can add to the line and we've had really good feedback like I say, and it's been fun researching it and digging into it and really enjoys staying on top of this stuff and seeing who's doing what and how they're doing it and things like that. Ian has been crushing it over on the marketing side. We just got up on Drug Report last week. I think we might be the first CBD company.
Matt Baum: 22:54 Oh, really?
Spencer Schelp: 22:54 Yeah. So that was super [crosstalk 00:22:54].
Matt Baum: 22:55 They're not demonizing it and saying like, "You guys are trying to kill children or anything" or,…?
Spencer Schelp: 22:58 Right. And they took our money, they took our money straightaway.
Matt Baum: 23:02 I mean I suppose at the end of the day, they'll take anybody's money.
Spencer Schelp: 23:04 Yeah. That might have been one of the things that kind of saved our butter early on is that people wouldn't take our money. You know what I mean? We didn't have that much to spend and we couldn't be on Google, Facebook. You couldn't advertise in any of those places.
Matt Baum: 23:17 Yeah, that's true.
Spencer Schelp: 23:17 So now these things have come around and we've got a little more refined focus. But yeah, they're so real super proud, super excited for us and right now really excited for Ian to get that done. That was a pretty good deal for us.
Matt Baum: 23:29 So tell me about your-
Spencer Schelp: 23:31 [crosstalk 00:23:31] pretty well over the weekend, too.
Matt Baum: 23:32 Tell me about the Pure American Hemp Oil, your product itself. It's a tincture, correct? The CBN.
Spencer Schelp: 23:38 Yeah, it's a tincture. It's 30 milliliter or one ounce tincture standard bottle. 150 milligrams of CBN plus melatonin.
Matt Baum: 23:48 Okay.
Spencer Schelp: 23:48 Right. We're around three milligrams of melatonin in there.
Matt Baum: 23:52 How much CBD is in there?
Spencer Schelp: 23:54 I was just looking at that. We're probably going to be close to about another 150 or so at the labs out. I was trying to do the math before we got on here, but yeah. I didn't put that on there, but that should be on the panel actually. You know, everything is in an organic MCT oil and then we get a [crosstalk 00:24:15] flavor in there.
Matt Baum: 24:14 That's cool. That's very cool. That was my next question. That's awesome.
Spencer Schelp: 24:17 Yeah, yeah. That's a big one, too. You got to have that organics. I mean, all these things are… You know, they leach toxins, right?
Matt Baum: 24:24 Right.
Spencer Schelp: 24:25 Your Palm trees, your hemp. I mean, all that stuff, it sucks all the nastiness out of the ground. Another beauty of the plant but we're big on that, and it's about double. Right? But that's again not telling you guys anything you don't know. It's always organic, vegan, vegetarian, all that good stuff.
Matt Baum: 24:43 That's awesome.
Spencer Schelp: 24:43 It's got lots of bugs on there, a lot of little stickers and stamps.
Matt Baum: 24:47 That's totally awesome. Of course, we'll have links in the show notes for this to check out the new product and stuff. I would love to actually scoop that I have trouble sleeping. So this would be great.
Spencer Schelp: 24:58 Go get your bottle.
Matt Baum: 24:58 Yeah, that'd be fantastic. I used to take sleep aids and whatnot and I found CBD. Taking it during the day actually helped me sleep later on. You know, I would take it in the morning and I would take it at night. And then Ian sent me some of the melatonin capsules that you have that are CBD and melatonin, and those are great.
Spencer Schelp: 25:18 Yep.
Matt Baum: 25:18 Those were totally great. I got all tricky with it and thought like, "Well, if I only take one then I'll just get four good hours of sleep." No, it knocked me out. It was great. You know?
Spencer Schelp: 25:30 That's awesome. I love those caps. I mean it's just a consistent dose every time. You can travel with them pretty easy, pretty slick deal, and that's organic MCT powder that that's mixed with. So…
Matt Baum: 25:42 And non-addictive and you don't wake up feeling hangover. You're not all fuzzy like you took a sleep aid, you know. That's what I really like about this stuff.
Spencer Schelp: 25:50 Proof is in the pudding for us. Right?
Matt Baum: 25:51 Right.
Spencer Schelp: 25:51 If it works for our client base, then it works for us, right? We're our best clients, our moms or parents and stuff like that. But if it works for us, we're competent rolling it out and we've had really good feedback. We're already looking at the next incarnation of it, and it's actually helped us separate ourselves a little bit. It's such a crowded field right now out there.
Matt Baum: 26:12 Oh, yeah. Oh, yeah.
Spencer Schelp: 26:13 I mean that's one thing we don't really worry too much about is what everybody else is doing. But when you're trying to fight for shelf space, I mean, who doesn't have a 600 tincture, right? You know what I mean? So if you can kind of pair this up, and our pet stuff has always been good to us in our price points. You know what I mean? We're super proud of where we are with pricing and stuff.
Matt Baum: 26:35 Yeah. I use the Bane's Bites for my puppy and he loves it. It's great. When at the end of the day, he can't settle down, Bane's bites. He chills out and I'm like, "All right." You know?
Spencer Schelp: 26:43 Everybody wins.
Matt Baum: 26:44 Yeah, exactly.
Spencer Schelp: 26:44 That's something, too. It's people spend more money on their pets than they do themselves. Right?
Matt Baum: 26:49 It's true. Yeah. It's true.
Spencer Schelp: 26:49 So happy to have that. It's kind of an impulse buy for people. The other thing is pets don't know placebos, right? If your dog is limping around or it's all spun out, right? And you give him one of those, he's not going to be like, "Oh, I just got CBD. I better be chill." You know he's going to be-
Matt Baum: 27:06 Right. Well, I read about it and it told me that I should have pets.
Spencer Schelp: 27:11 Yeah, right. Yeah. My favorite celebrity uses this, so I better be [crosstalk 00:27:14] today.
Matt Baum: 27:14 So it's got to be good, right? I mean-
Spencer Schelp: 27:16 Yeah.
Matt Baum: 27:16 Megan Rapinoe wouldn't tell me it kicks ass if it didn't. So, you know.
Spencer Schelp: 27:20 Yeah. Maybe that's what we need. We need a celebrity puppy influencer or something like that out there.
Matt Baum: 27:25 There you go. Yeah.
Spencer Schelp: 27:26 Then can influence everybody out.
Matt Baum: 27:28 A talking dog. That's what you need right there.
Spencer Schelp: 27:33 Yeah, that's right. Triumph, right? Triumph the Comic Dog?
Matt Baum: 27:35 There you go. Yeah. Although we might make fun of you guys, but if you're into that, that's cool. You know?
Spencer Schelp: 27:41 Little abuse. It's all right. [inaudible 00:27:43].
Matt Baum: 27:43 Spencer, thanks so much for coming in and talking about this, and we've talked about CBN. We've touched on it before, but I feel like when we first started talking about it, everybody was still trying to feel out what it actually does. Can I ask you? You said so it has sedative properties. Do you know when those studies came out that started to show that CBN does have sedative properties?
Spencer Schelp: 28:04 I found them this year, and I'd have to check when that came out, but yeah, I found them last couple of months, and I want to say-
Matt Baum: 28:10 This is all very new info though, right?
Spencer Schelp: 28:12 It is. It is.
Matt Baum: 28:15 Okay.
Spencer Schelp: 28:15 I got them on about everybody's mailing lists, so I've been seeing stuff coming out of people touting it by the kilo, by the leaf and then the finished product, and that tells me that it's fairly new, but I'm sure if you searched one in your DuckDuckGo or wherever you search with, you come up with that. But yeah, that's-
Matt Baum: 28:33 I'm a big man myself. Let me tell you.
Spencer Schelp: 28:35 There you go.
Matt Baum: 28:37 Big bang guy.
Spencer Schelp: 28:38 See?
Matt Baum: 28:38 Yeah. Again, I want to send out a huge thanks to Spencer from Pure American Hemp Oil coming on and talking CBN with us. Like I said, there will be links in the show notes to pureamericanhempoil.com. If you want to try out their new CBN tincture and links to all the studies we talked about, including the hyper-technical definition of chromatography on Wikipedia if you would like to take a deep dive there.
Matt Baum: 29:13 And as always, you can find a complete written transcript of the show for accessibility for everyone. As always, I want to send out a huge thank you to everybody that has been downloading, listening to this show, commenting on it, and giving us reviews. Your reviews really, really help more than you know to get this information in front of other people. So please, if you have a chance, go to iTunes, give us a star rating or go to your podcast aggregator app and give us a thumbs up or a star or whatever they do there. It's such a huge help. I can't stress it enough.
Matt Baum: 29:47 If you listened to today's episode and you have questions, then call us (402) 819-6417 and leave us a message with your hemp-related questions and you could hear them answered by myself and editor in chief of ministryofhemp.com Kit O'Connell. We love to hear from you guys and we would love to answer your questions on the show. So please become a part of this show. Call us or tweet at us @MinistryofHemp. Hit us up on Facebook/ministryofhemp, and you can be a part of this show. Over at ministryofhemp.com, we have got some huge Black Friday and cyber Monday sale information coming out this Thursday. That'll be both on the site and in our mailing list. So watch for that.
Matt Baum: 30:39 Until next time, this is Matt Baum wishing you all a happy Thanksgiving and saying, remember to take care of yourself, take care of others, and make good decisions. Will you? This is the Ministry of Hemp signing off.
Two of our favorite things taste (and feel) great together: CBD and chocolate. In this episode of the Ministry of Hemp podcast, our host...
Hemp testing is a vital part of the hemp supply chain, but currently it can be expensive, unreliable, and too slow. This week on...
Bioavailability is the measure of how much of any given substance, like CBD gets absorbed into the body. Is it possible to make CBD...